Mentoring and Patient Oriented Research at the Nexus of Unhealthy Alcohol Use and HIV
不健康饮酒与艾滋病毒关系的指导和以患者为导向的研究
基本信息
- 批准号:10685992
- 负责人:
- 金额:$ 16.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-03 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAddressAdoptionAgeAlcohol consumptionAlcoholsAlgorithmsAreaAwardBehavioralCardiovascular DiseasesCaringClinicClinicalCognitionCognitive TherapyCollaborationsCommunicable DiseasesComputersConsolidated Framework for Implementation ResearchContinuity of Patient CareDevelopment PlansDisciplineDiscipline of NursingEffectivenessEnvironmentEpidemicEpidemiologyFacultyFundingFutureGoalsHIVHealthHigh PrevalenceIndividualInfrastructureInternal MedicineInternistInterventionIntervention StudiesInterviewK-Series Research Career ProgramsKnowledgeLeadershipLiver diseasesMaintenanceMentorsMentorshipMethodsMidcareer Investigator Award in Patient-Oriented ResearchNational Institute of Allergy and Infectious DiseaseNational Institute on Alcohol Abuse and AlcoholismOutcomeOutcome MeasurePatient CarePatientsPersonsPharmacotherapyPositioning AttributePreparationPreventivePrintingProviderPublic HealthReach, Effectiveness, Adoption, Implementation, and MaintenanceResearchResearch ActivityResearch MethodologyResearch PersonnelResourcesRiskRisk BehaviorsScholarshipScientistSiteSpecialistStrategic PlanningStudentsSurveysSystemTestingTimeTrainingTraining ActivityUnited StatesUnited States National Institutes of HealthWomanWorkage relatedalcohol abuse therapyalcohol consequencesalcohol interventionalcohol misusealcohol researcharmbehavioral clinical trialbrief interventioncare coordinationcareercareer developmentclinical research sitecohortcommunity settingcomorbiditycontextual factorsdesigneffectiveness testingefficacy trialevidence baseexperiencefrailtyimplementation facilitationimplementation facilitatorsimplementation researchimprovedinterestleadership developmentmedical schoolsmid-career facultymortalitynext generationpatient orientedpatient oriented researchpatient-level barrierspharmacologicpost interventionprogramsreduced alcohol usescreeningskillstransmission processtreatment strategy
项目摘要
Unhealthy alcohol use among persons with HIV (PWH) has deleterious effects on retention in the HIV Care
Continuum, increases HIV transmission risk behaviors, complicates the management of age-related
comorbidities and increases mortality. I am a general internist and clinical HIV specialist. My research career
over the past 14 years has focused at the nexus of HIV and alcohol use. My research and scholarship have
contributed to the understanding of the epidemiology and clinical consequences of alcohol use among PWH,
and to the adaptation and testing of interventions for unhealthy alcohol use among PWH, particularly women. I
seek this K24 Mid-Career Investigator Award to 1) Expand my patient oriented research skills and experience
in implementation research, in order to rigorously implement evidence based alcohol interventions for PWH in
clinical and community settings, allowing me to expand my patient oriented intervention research from trials of
efficacy to effectiveness and implementation; and 2) increase mentoring time, enhance my mentoring and
leadership skills, and thereby expand the cadre of junior faculty and trainees pursuing research careers
focused on alcohol and HIV. I will accomplish these goals through didactics, training, direct experience and
mentorship from experts in implementation research, mentoring and leadership development. Throughout this
award period I will work closely with mentees to develop individual development plans tailored to their values
and goals which will serve as a blue print for their training activities. The new research proposed in this award
will capitalize on the existing resources and infrastructure of the NIAAA funded Alcohol Research Consortium
in HIV (ARCH), nested in the CFAR Network of Integrated Clinical Systems (CNICS), a multi-site clinical cohort
of PWH receiving care across 8 HV clinics in the United States. ARCH is testing the effectiveness of an alcohol
treatment algorithm integrated into three HIV clinics. With implementation research collaborators and trainees,
and skills gained from proposed K24 career development activities, I will use mixed methods to explore and
evaluate multi-level factors that influence adoption, implementation and maintenance of this approach to
alcohol treatment in HIV clinical settings. This mixed methods research, which includes in-depth interviews and
quantitative surveys, will provide a number of opportunities for trainees interested in implementation research
focused on alcohol and HIV. I have a strong record of research funding, and am a long-standing investigator
with the Johns Hopkins HIV Clinical Cohort, ARCH, and a behavioral clinical trials program for women with and
at risk of HIV. These resources, combined with the strong scientific environment at Johns Hopkins, serve as an
outstanding platform to train the next generation of investigators in the areas of alcohol use and HIV.
艾滋病毒感染者(PWH)中不健康的酒精使用对艾滋病毒护理的保留产生有害影响
连续性,增加了艾滋病毒传播的风险行为,使年龄相关的管理复杂化,
并发症和增加死亡率。我是一名普通内科医生和临床艾滋病专家。我的研究生涯
在过去的14年里,我们一直专注于艾滋病毒和酒精使用的关系。我的研究和奖学金
有助于了解威尔斯亲王医院酗酒的流行病学和临床后果,
以及对威尔斯亲王医院,特别是妇女,不健康酒精使用的干预措施进行调整和测试。我
寻求这个K24中期职业研究者奖,以1)扩展我以患者为导向的研究技能和经验
在实施研究中,为了严格实施基于证据的酒精干预措施,
临床和社区环境,使我能够扩大我的病人为导向的干预研究,从试验
从功效到有效性和实施;以及2)增加指导时间,加强我的指导,
领导技能,从而扩大初级教师和学员追求研究事业的干部
专注于酒精和艾滋病我将通过教学法、培训、直接经验和
在实施研究、指导和领导力发展方面得到专家的指导。贯穿本
奖励期我将与学员密切合作,根据他们的价值观制定个人发展计划
和目标,作为他们训练活动的蓝图。该奖项中提出的新研究
将利用NIAAA资助的酒精研究联盟的现有资源和基础设施
HIV(HIV),嵌套在CFAR综合临床系统网络(CNICS)中,这是一个多中心临床队列
在美国的8个HV诊所接受治疗的PWH。他正在测试一种酒精的有效性
治疗算法整合到三个艾滋病诊所。与实施研究合作者和受训者一起,
从建议的K24职业发展活动中获得的技能,我将使用混合方法来探索和
评估影响采用、实施和维持这一方法的多层次因素,
在艾滋病临床环境中的酒精治疗。这种混合方法的研究,其中包括深入访谈,
定量调查将为对执行研究感兴趣的受训人员提供一些机会
专注于酒精和艾滋病我有一个强大的研究基金的记录,是一个长期的调查员
与约翰霍普金斯艾滋病毒临床队列,艾滋病,和行为临床试验计划的妇女与
有感染艾滋病毒的风险。这些资源,再加上约翰霍普金斯强大的科学环境,
这是一个出色的平台,可以在酒精使用和艾滋病毒领域培训下一代调查人员。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Does a Survivorship Model of Opioid Use Disorder Improve Public Stigma or Policy Support? A General Population Randomized Experiment.
阿片类药物使用障碍的生存模型是否会改善公众耻辱或政策支持?
- DOI:10.1007/s11606-022-07865-y
- 发表时间:2023
- 期刊:
- 影响因子:5.7
- 作者:Pytell,JarrattD;Chander,Geetanjali;Thakrar,AshishP;Ogunwole,SMichelle;McGinty,EmmaE
- 通讯作者:McGinty,EmmaE
Hepatitis C Treatment in People With HIV: Potential to Eliminate Disease and Disparity.
艾滋病毒感染者的丙型肝炎治疗:消除疾病和差异的潜力。
- DOI:10.1093/infdis/jiad433
- 发表时间:2024
- 期刊:
- 影响因子:0
- 作者:Falade-Nwulia,Oluwaseun;Lesko,CatherineR;Fojo,AnthonyT;Keruly,JeanneC;Moore,RichardD;Sutcliffe,CatherineG;Mehta,ShrutiH;Chander,Geetanjali;Thomas,DavidL;Sulkowski,Mark
- 通讯作者:Sulkowski,Mark
Common Elements Treatment Approach (CETA) for unhealthy alcohol use among persons with HIV in Zambia: Study protocol of the ZCAP randomized controlled trial.
- DOI:10.1016/j.abrep.2020.100278
- 发表时间:2020-12-01
- 期刊:
- 影响因子:0
- 作者:Kane, Jeremy C;Sharma, Anjali;Vinikoor, Michael J
- 通讯作者:Vinikoor, Michael J
Testing the validity of the AUDIT-C and AUDIT-3 to detect unhealthy alcohol use among high-risk populations in Zambia: A secondary analysis from two randomized trials.
- DOI:10.1016/j.drugalcdep.2021.109156
- 发表时间:2021-12-01
- 期刊:
- 影响因子:4.2
- 作者:Inoue S;Chitambi C;Vinikoor MJ;Kanguya T;Murray LK;Sharma A;Chander G;Paul R;Mwenge MM;Munthali S;Kane JC
- 通讯作者:Kane JC
Efficacy of the Common Elements Treatment Approach (CETA) for Unhealthy Alcohol Use Among Adults with HIV in Zambia: Results from a Pilot Randomized Controlled Trial.
- DOI:10.1007/s10461-021-03408-4
- 发表时间:2022-03
- 期刊:
- 影响因子:4.4
- 作者:Kane JC;Sharma A;Murray LK;Chander G;Kanguya T;Skavenski S;Chitambi C;Lasater ME;Paul R;Cropsey K;Inoue S;Bosomprah S;Danielson CK;Chipungu J;Simenda F;Vinikoor MJ
- 通讯作者:Vinikoor MJ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GEETANJALI CHANDER其他文献
GEETANJALI CHANDER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GEETANJALI CHANDER', 18)}}的其他基金
HIV and Substance Use Cohort Coordinating Center for Emerging and High Impact Scientific Cross Cohort Studies: HIV SUCCESS
艾滋病毒和药物使用队列协调中心新兴和高影响科学跨队列研究:艾滋病毒成功
- 批准号:
10676432 - 财政年份:2023
- 资助金额:
$ 16.86万 - 项目类别:
Training in Equity and Structural Solutions in Addictions (TESSA)
成瘾公平和结构性解决方案培训(TESSA)
- 批准号:
10625735 - 财政年份:2023
- 资助金额:
$ 16.86万 - 项目类别:
Mentoring and Patient Oriented Research at the Nexus of Unhealthy Alcohol Use and HIV
不健康饮酒与艾滋病毒关系的指导和以患者为导向的研究
- 批准号:
10608555 - 财政年份:2022
- 资助金额:
$ 16.86万 - 项目类别:
Alcohol Research Consortium in HIV: Implementation Research Arm
艾滋病毒酒精研究联盟:实施研究部门
- 批准号:
10304375 - 财政年份:2021
- 资助金额:
$ 16.86万 - 项目类别:
Alcohol Research Consortium in HIV: Ending the HIV Epidemic through interventions and Epidemiology at the intersection of the alcohol and HIV care Continua
艾滋病毒酒精研究联盟:通过酒精和艾滋病毒护理交叉点的干预措施和流行病学结束艾滋病毒流行 Continua
- 批准号:
10304371 - 财政年份:2021
- 资助金额:
$ 16.86万 - 项目类别:
Alcohol Research Consortium in HIV: Administrative Core
艾滋病毒酒精研究联盟:行政核心
- 批准号:
10304372 - 财政年份:2021
- 资助金额:
$ 16.86万 - 项目类别:
Impact of alcohol reduction on Tuberculosis drug levels, TB adherence and gut microbiome
减少饮酒对结核病药物水平、结核病依从性和肠道微生物群的影响
- 批准号:
10544859 - 财政年份:2020
- 资助金额:
$ 16.86万 - 项目类别:
Hybrid trial for Alcohol reduction among people with TB and HIV in India (HATHI)
印度结核病和艾滋病毒感染者减少饮酒的混合试验 (HATHI)
- 批准号:
10658901 - 财政年份:2020
- 资助金额:
$ 16.86万 - 项目类别:
Hybrid trial for Alcohol reduction among people with TB and HIV in India (HATHI)
印度结核病和艾滋病毒感染者减少饮酒的混合试验 (HATHI)
- 批准号:
10252751 - 财政年份:2020
- 资助金额:
$ 16.86万 - 项目类别:
Hybrid trial for Alcohol reduction among people with TB and HIV in India (HATHI)
印度结核病和艾滋病毒感染者减少饮酒的混合试验 (HATHI)
- 批准号:
10435573 - 财政年份:2020
- 资助金额:
$ 16.86万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 16.86万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 16.86万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 16.86万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 16.86万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 16.86万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 16.86万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 16.86万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 16.86万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 16.86万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 16.86万 - 项目类别:
Research Grant